CARCINOMA

This early-stage study tested a new treatment for people with advanced non-small cell lung cancer that had grown or returned after standard therapy. Researchers took patients' own immune cells, modified them in a lab to recognize and attack cancer cells, and infused them back aft…

This study tested whether adding a drug called aflibercept to standard chemotherapy (docetaxel) helps people with advanced non-small cell lung cancer live longer when their first treatment stops working. Over 900 participants received either the new combination or chemotherapy pl…

This study tested a short-term psychodynamic therapy for 24 adults with advanced solid tumors and high psychological distress. The goal was to see if the therapy was safe, acceptable, and feasible, not to cure the cancer. Results focused on side effects, drop-out rates, and patie…

This study tested a new method called the mass response biomarker to see if it can predict how well a cancer patient will respond to specific treatments. Researchers collected tumor cells from 72 adults with various cancers using fluid samples or tissue biopsies. The goal was to …

This study looked at whether certain chemicals called organochlorines, which are stored in body fat, are linked to pancreatic cancer. Researchers compared levels of these chemicals in fat and urine samples from 56 people—some with pancreatic cancer and some without. The goal was …

This study tested a financial navigation program for 258 cancer patients in rural and non-rural North Carolina clinics. The goal was to see if helping patients manage costs could reduce financial toxicity and improve quality of life. Participants had high financial distress and r…